Lingdao Capital
Overview
Lingdao Capital is a venture capital firm founded in 2018 that focuses on investing in the frontier of China's biomedical field.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Shanghai Hanyu Medical Technology | Mar 2021 | Series D Extension | Co-investor |
| CH Biomedical | Aug 2021 | Series D | Co-investor |
| Singlera Genomics Inc. | Dec 2020 | Series B | Co-investor |
| TechnoDerma Medicines Inc. | Apr 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Lingdao Capital based?
Lingdao Capital is headquartered in Nanjing, China.
When was Lingdao Capital founded?
Lingdao Capital was founded in 2018.
How many portfolio companies does Lingdao Capital have?
Lingdao Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in Lingdao Capital's portfolio?
Portfolio companies visible on Caplight include Shanghai Hanyu Medical Technology, CH Biomedical, Singlera Genomics Inc., TechnoDerma Medicines Inc..
What was Lingdao Capital's most recent investment shown here?
Lingdao Capital's most recent investment in this portfolio sample was in CH Biomedical in 2021.
What sectors does Lingdao Capital focus on?
Lingdao Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Lingdao Capital focus on?
Lingdao Capital typically invests at the Early stage.
What is Lingdao Capital's AUM?
Lingdao Capital's assets under management are estimated at over $275.0M.